Research programme: West Nile virus vaccines - Bavarian Nordic
Alternative Names: MVA-BN® WNVLatest Information Update: 24 May 2007
At a glance
- Originator Bavarian Nordic
- Class Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued West Nile virus infections
Most Recent Events
- 24 May 2007 Discontinued - Preclinical for West Nile virus infections prevention in Denmark (unspecified route)
- 24 May 2007 Discontinued - Preclinical for West Nile virus infections prevention in Germany (unspecified route)
- 09 Jan 2004 No development reported - Preclinical for West Nile virus infections in Denmark (unspecified route)